<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    		<meta name="keywords" content="Acamprosate,Acamprosate.png,2004,2005,2007,ATC code N07,Abstinence,Addiction,Adverse drug reaction,Alcohol,Alcohol dependence" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (English)" />
		<link rel="copyright" href="../../../COPYING.html" />
    <title>Acamprosate - Wikipedia, the free encyclopedia</title>
    <style type="text/css">/*<![CDATA[*/ @import "../../../skins/htmldump/main.css"; /*]]>*/</style>
    <link rel="stylesheet" type="text/css" media="print" href="../../../skins/common/commonPrint.css" />
    <!--[if lt IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE50Fixes.css";</style><![endif]-->
    <!--[if IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE55Fixes.css";</style><![endif]-->
    <!--[if IE 6]><style type="text/css">@import "../../../skins/monobook/IE60Fixes.css";</style><![endif]-->
    <!--[if IE]><script type="text/javascript" src="../../../skins/common/IEFixes.js"></script>
    <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
    <script type="text/javascript" src="../../../skins/common/wikibits.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/md5.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/utf8.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/lookup.js"></script>
    <script type="text/javascript" src="../../../raw/gen.js"></script>        <style type="text/css">/*<![CDATA[*/
@import "../../../raw/MediaWiki%7ECommon.css";
@import "../../../raw/MediaWiki%7EMonobook.css";
@import "../../../raw/gen.css";
/*]]>*/</style>          </head>
  <body
    class="ns-0">
    <div id="globalWrapper">
      <div id="column-content">
	<div id="content">
	  <a name="top" id="contentTop"></a>
	        <h1 class="firstHeading">Acamprosate</h1>
	  <div id="bodyContent">
	    <h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
	    <div id="contentSub"></div>
	    	    <div class="usermessage">You have <a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">new messages</a> (<a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">last change</a>).</div>	    <!-- start content -->
	    <table id="drugInfoBox" style="float: right; clear: right; margin: 0 0 0.5em 1em; background: #ffffff;" class="toccolours" border="0" cellpadding="1" align="right" width="280">
<tr>
<td align="center" colspan="2"><a href="../../../a/c/a/Image%7EAcamprosate.svg_e2cc.html" class="image" title=""><img src="../../../upload/shared/thumb/e/ef/Acamprosate.svg/220px-Acamprosate.svg.png" alt="" width="220" height="119" longdesc="../../../a/c/a/Image%7EAcamprosate.svg_e2cc.html" /></a></td>
</tr>
<tr>
<td align="center" colspan="2">
<div style="font-size:medium; line-height:167%;">Acamprosate</div>
</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Systematic (<a href="../../../i/n/t/International_Union_of_Pure_and_Applied_Chemistry_nomenclature_efd4.html" title="International Union of Pure and Applied Chemistry nomenclature">IUPAC</a>) name</b></td>
</tr>
<tr>
<td bgcolor="#EEEEEE" style="text-align: center; vertical-align: top;" colspan="2"><span style="font-size:11px">calcium 3-acetylaminopropane-1-sulfonate</span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Identifiers</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" width="90"><a href="../../../c/a/s/CAS_registry_number_4b20.html" title="CAS registry number">CAS number</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://www.nlm.nih.gov/cgi/mesh/2006/MB_cgi?term=77337-76-9&amp;rn=1" class="external text" title="http://www.nlm.nih.gov/cgi/mesh/2006/MB_cgi?term=77337-76-9&amp;rn=1" rel="nofollow">77337-76-9</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../a/n/a/Anatomical_Therapeutic_Chemical_Classification_System_186e.html" title="Anatomical Therapeutic Chemical Classification System">ATC code</a></td>
<td bgcolor="#EEEEEE"><a href="../../../a/t/c/ATC_code_N07_2623.html" title="ATC code N07">N07</a><span class="reflink plainlinksneverexpand"><a href="http://www.whocc.no/atcddd/indexdatabase/index.php?query=N07BB03" class="external text" title="http://www.whocc.no/atcddd/indexdatabase/index.php?query=N07BB03" rel="nofollow">BB03</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../p/u/b/PubChem_a50b.html" title="PubChem">PubChem</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=71158" class="external text" title="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=71158" rel="nofollow">71158</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../d/r/u/DrugBank_2050.html" title="DrugBank">DrugBank</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://redpoll.pharmacy.ualberta.ca/drugbank/cgi-bin/getCard.cgi?CARD=APRD00661" class="external text" title="http://redpoll.pharmacy.ualberta.ca/drugbank/cgi-bin/getCard.cgi?CARD=APRD00661" rel="nofollow">APRD00661</a></span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Chemical data</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../c/h/e/Chemical_formula.html" title="Chemical formula">Formula</a></td>
<td bgcolor="#EEEEEE"><a href="../../../c/a/r/Carbon.html" title="Carbon">C</a><sub>10</sub><a href="../../../h/y/d/Hydrogen.html" title="Hydrogen">H</a><sub>20</sub><a href="../../../n/i/t/Nitrogen.html" title="Nitrogen">N</a><sub>2</sub><a href="../../../o/x/y/Oxygen.html" title="Oxygen">O</a><sub>8</sub><a href="../../../s/u/l/Sulfur.html" title="Sulfur">S</a><sub>2</sub><a href="../../../c/a/l/Calcium.html" title="Calcium">Ca</a><sup id="_ref-fda_0" class="reference"><a href="#_note-fda" title="">[1]</a></sup></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../m/o/l/Molecular_mass.html" title="Molecular mass">Mol. mass</a></td>
<td bgcolor="#EEEEEE">181.211 g/mol</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Pharmacokinetic data</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../b/i/o/Bioavailability.html" title="Bioavailability">Bioavailability</a></td>
<td bgcolor="#EEEEEE">11%<sup id="_ref-fda_1" class="reference"><a href="#_note-fda" title="">[1]</a></sup></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../p/l/a/Plasma_protein_binding.html" title="Plasma protein binding">Protein binding</a></td>
<td bgcolor="#EEEEEE">Negligible<sup id="_ref-fda_2" class="reference"><a href="#_note-fda" title="">[1]</a></sup></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../d/r/u/Drug_metabolism.html" title="Drug metabolism">Metabolism</a></td>
<td bgcolor="#EEEEEE">Nil<sup id="_ref-fda_3" class="reference"><a href="#_note-fda" title="">[1]</a></sup></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../b/i/o/Biological_half-life.html" title="Biological half-life">Half life</a></td>
<td bgcolor="#EEEEEE">20 to 33 <a href="../../../h/o/u/Hour.html" title="Hour">hours</a><sup id="_ref-fda_4" class="reference"><a href="#_note-fda" title="">[1]</a></sup></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../e/x/c/Excretion.html" title="Excretion">Excretion</a></td>
<td bgcolor="#EEEEEE"><a href="../../../r/e/n/Renal.html" title="Renal">Renal</a><sup id="_ref-fda_6" class="reference"><a href="#_note-fda" title="">[1]</a></sup></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Therapeutic considerations</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../p/r/e/Pregnancy_category.html" title="Pregnancy category">Pregnancy cat.</a></td>
<td bgcolor="#EEEEEE">
<p>C<sup id="_ref-deluca_0" class="reference"><a href="#_note-deluca" title="">[2]</a></sup> <small>(<a href="../../../u/n/i/United_States_09d4.html" title="United States">US</a>)</small> B2 <small>(<a href="../../../a/u/s/Australia.html" title="Australia">AU</a>)</small></p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../r/e/g/Regulation_of_therapeutic_goods.html" title="Regulation of therapeutic goods">Legal status</a></td>
<td bgcolor="#EEEEEE">
<p><a href="../../../p/r/e/Prescription_drug.html" title="Prescription drug">POM</a><small>(<a href="../../../u/n/i/United_Kingdom_5ad7.html" title="United Kingdom">UK</a>)</small> <a href="../../../p/r/e/Prescription_drug.html" title="Prescription drug"><span class="Unicode">℞</span><small>-only</small></a><small>(<a href="../../../u/n/i/United_States_09d4.html" title="United States">US</a>)</small></p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../r/o/u/Route_of_administration.html" title="Route of administration">Routes</a></td>
<td bgcolor="#EEEEEE">Oral (333mg tablets of acamprosate calcium)<sup id="_ref-fda_5" class="reference"><a href="#_note-fda" title="">[1]</a></sup></td>
</tr>
</table>
<p><b>Acamprosate</b>, also known by the brand name <b>Campral</b>®, is a drug used for treating <a href="../../../a/l/c/Alcohol_dependence.html" title="Alcohol dependence">alcohol dependence</a>.</p>
<p>Acamprosate is thought to stabilize the chemical balance in the <a href="../../../b/r/a/Brain.html" title="Brain">brain</a> that would otherwise be disrupted by alcoholism, possibly by blocking glutaminergic <i>N</i>-methyl-<small>D</small>-aspartate <a href="../../../r/e/c/Receptor.html" title="Receptor">receptors</a>, while <a href="../../../g/a/m/Gamma-aminobutyric_acid.html" title="Gamma-aminobutyric acid">gamma-aminobutyric acid</a> type A receptors are activated.<sup id="_ref-americanfamilyphysician_0" class="reference"><a href="#_note-americanfamilyphysician" title="">[3]</a></sup> Reports indicate that acamprosate only works with a combination of attending <a href="../../../s/u/p/Support_group.html" title="Support group">support groups</a> and <a href="../../../a/b/s/Abstinence.html" title="Abstinence">abstinence</a> from <a href="../../../a/l/c/Alcohol.html" title="Alcohol">alcohol</a>.<sup id="_ref-Mason2001_0" class="reference"><a href="#_note-Mason2001" title="">[4]</a></sup> Certain serious side effects include <a href="../../../a/l/l/Allergic_reaction.html" title="Allergic reaction">allergic reactions</a>, <a href="../../../c/a/r/Cardiac_arrhythmia.html" title="Cardiac arrhythmia">irregular heartbeats</a>, and low or high <a href="../../../b/l/o/Blood_pressure.html" title="Blood pressure">blood pressure</a>, while less serious side effects include <a href="../../../h/e/a/Headache.html" title="Headache">headaches</a>, <a href="../../../i/n/s/Insomnia.html" title="Insomnia">insomnia</a>, and <a href="../../../i/m/p/Impotence.html" title="Impotence">impotence</a>.<sup id="_ref-0" class="reference"><a href="#_note-0" title="">[5]</a></sup> Acamprosate should not be taken by people with <a href="../../../k/i/d/Kidney.html" title="Kidney">kidney</a> problems or allergies to the drug.<sup id="_ref-1" class="reference"><a href="#_note-1" title="">[6]</a></sup></p>
<p>Campral is manufactured and marketed by <a href="../../../m/e/r/Merck_KGaA_7cdd.html" title="Merck KGaA">Merck KGaA</a>. It is sold as 333 <a href="../../../m/i/l/Milligram.html" title="Milligram">mg</a> <a href="../../../w/h/i/White.html" title="White">white</a> and <a href="../../../o/d/o/Odor.html" title="Odor">odorless</a> <a href="../../../t/a/b/Tablet.html" title="Tablet">tablets</a> of acamprosate calcium, which is the equivalent of 300mg of acamprosate.<sup id="_ref-fda_7" class="reference"><a href="#_note-fda" title="">[1]</a></sup></p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Approval"><span class="tocnumber">1</span> <span class="toctext">Approval</span></a></li>
<li class="toclevel-1"><a href="#Study_results"><span class="tocnumber">2</span> <span class="toctext">Study results</span></a></li>
<li class="toclevel-1"><a href="#Physiological_action"><span class="tocnumber">3</span> <span class="toctext">Physiological action</span></a>
<ul>
<li class="toclevel-2"><a href="#Possible_neuroprotection"><span class="tocnumber">3.1</span> <span class="toctext">Possible neuroprotection</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">4</span> <span class="toctext">References</span></a></li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="Approval" id="Approval"></a></p>
<h2><span class="editsection">[<a href="../../../a/c/a/Acamprosate.html" title="Edit section: Approval">edit</a>]</span> <span class="mw-headline">Approval</span></h2>
<p>While the <a href="../../../f/o/o/Food_and_Drug_Administration_b75c.html" title="Food and Drug Administration">Food and Drug Administration</a> (FDA) in the <a href="../../../u/n/i/United_States_09d4.html" title="United States">United States</a> approved this drug in July 2004, it has been legal in <a href="../../../e/u/r/Europe.html" title="Europe">Europe</a> since 1989. After it approved the drug, the FDA released this statement:</p>
<dl>
<dd>"While its mechanism of action is not fully understood, Campral is thought to act on the <a href="../../../b/r/a/Brain.html" title="Brain">brain</a> pathways related to alcohol abuse. Campral was demonstrated to be safe and effective by multiple <a href="../../../p/l/a/Placebo.html" title="Placebo">placebo</a>-controlled <a href="../../../c/l/i/Clinical_trial.html" title="Clinical trial">clinical studies</a> involving alcohol-dependent patients who had already been withdrawn from alcohol, (i.e., <a href="../../../d/r/u/Drug_rehabilitation.html" title="Drug rehabilitation">detoxified</a>). Campral proved superior to placebo in maintaining <a href="../../../a/b/s/Abstinence.html" title="Abstinence">abstinence</a> (keeping patients off alcohol consumption), as indicated by a greater percentage of acamprosate-treated subjects being assessed as continuously abstinent throughout treatment. Campral is not <a href="../../../a/d/d/Addiction.html" title="Addiction">addicting</a> and was generally well-tolerated in clinical trials. The most common <a href="../../../a/d/v/Adverse_drug_reaction.html" title="Adverse drug reaction">adverse events</a> reported for patients taking Campral included <a href="../../../h/e/a/Headache.html" title="Headache">headache</a>, <a href="../../../d/i/a/Diarrhea.html" title="Diarrhea">diarrhea</a>, <a href="../../../f/l/a/Flatulence.html" title="Flatulence">flatulence</a>, and <a href="../../../n/a/u/Nausea.html" title="Nausea">nausea</a>."<sup id="_ref-2" class="reference"><a href="#_note-2" title="">[7]</a></sup></dd>
</dl>
<p><a name="Study_results" id="Study_results"></a></p>
<h2><span class="editsection">[<a href="../../../a/c/a/Acamprosate.html" title="Edit section: Study results">edit</a>]</span> <span class="mw-headline">Study results</span></h2>
<p>The <a href="../../../s/c/r/Scripps_Research_Institute_83bb.html" title="Scripps Research Institute">Scripps Research Institute</a> conducted a <a href="../../../d/o/u/Double_blind.html" title="Double blind">double blind</a> study comparing the effectiveness between using acamprosate and <a href="../../../p/l/a/Placebo.html" title="Placebo">placebos</a> in combination with <a href="../../../p/s/y/Psychotherapy.html" title="Psychotherapy">psychotherapy</a>. The primary end-point evaluated was percentage of alcohol-free days. The researchers concluded that acamprosate is "safe and effective".<sup id="_ref-Mason2006_0" class="reference"><a href="#_note-Mason2006" title="">[8]</a></sup></p>
<p>Another study was conducted by <a href="../../../p/r/i/Princess_Alexandra_Hospital_ce19.html" title="Princess Alexandra Hospital">Princess Alexandra Hospital</a> in <a href="../../../b/r/i/Brisbane.html" title="Brisbane">Brisbane</a> comparing the use of acamprosate, <a href="../../../n/a/l/Naltrexone.html" title="Naltrexone">naltrexone</a>, and both drugs at once in a twelve-week study.<sup id="_ref-3" class="reference"><a href="#_note-3" title="">[9]</a></sup> Three groups of 59 patients were tested with <a href="../../../c/o/g/Cognitive_behavioral_therapy.html" title="Cognitive behavioral therapy">cognitive behavioral therapy</a>; each group with each form of treatment outlined for this study. The results are outlined below.</p>
<table class="wikitable">
<tr>
<th></th>
<th>Percentage attending program</th>
<th>Abstinence rates</th>
<th>Average number of days abstinence<sup>1</sup></th>
<th>Days until first breach of abstinence<sup>1</sup></th>
</tr>
<tr>
<td>Acamprosate group</td>
<td>66.1%</td>
<td>50.8%</td>
<td>45.07 days</td>
<td>26.79 days</td>
</tr>
<tr>
<td>Naltrexone group</td>
<td>79.7%</td>
<td>66.1%</td>
<td>49.95 days</td>
<td>26.7 days</td>
</tr>
<tr>
<td>Drug combination group</td>
<td>83.1%</td>
<td>67.8%</td>
<td>53.58 days</td>
<td>37.32 days</td>
</tr>
</table>
<dl>
<dd><sup>1</sup> <i>This statistic applies to patients who could not remain abstinent throughout the entire 84-day period.</i></dd>
</dl>
<p>This study concluded that a combination of medications was generally more popular and yielded better results than using either drug alone.</p>
<p><a name="Physiological_action" id="Physiological_action"></a></p>
<h2><span class="editsection">[<a href="../../../a/c/a/Acamprosate.html" title="Edit section: Physiological action">edit</a>]</span> <span class="mw-headline">Physiological action</span></h2>
<p>Alcohol inhibits activity of <a href="../../../b/i/o/Biochemical_receptor.html" title="Biochemical receptor">biochemical receptors</a> called <a href="../../../n/-/m/N-methyl-D-aspartate_receptor_12bc.html" title="N-methyl-D-aspartate receptor">N-methyl-D-aspartate receptors</a>, or NMDARs, so that chronic alcohol consumption leads to the overproduction of these receptors. Thus, sudden alcohol abstinence causes these excessive numbers of NMDARs to be more active than normal and to produce the symptoms of <a href="../../../d/e/l/Delirium_tremens.html" title="Delirium tremens">delirium tremens</a> and <a href="../../../e/x/c/Excitotoxicity.html" title="Excitotoxicity">excitotoxic</a> neuronal death.<sup id="_ref-4" class="reference"><a href="#_note-4" title="">[10]</a></sup> <a href="../../../w/i/t/Withdrawal.html" title="Withdrawal">Withdrawal</a> from alcohol induces a surge in release of excitatory <a href="../../../n/e/u/Neurotransmitter.html" title="Neurotransmitter">neurotransmitters</a> like <a href="../../../g/l/u/Glutamic_acid.html" title="Glutamic acid">glutamate</a>, which activates NMDARs.<sup id="_ref-5" class="reference"><a href="#_note-5" title="">[11]</a></sup> Acamprosate reduces this glutamate surge.<sup id="_ref-De_Witte_2005_0" class="reference"><a href="#_note-De_Witte_2005" title="">[12]</a></sup> The drug also protects cultured cells in excitotoxicity induced by ethanol withdrawal.<sup id="_ref-6" class="reference"><a href="#_note-6" title="">[13]</a></sup> and by glutamate exposure combined with ethanol withdrawal.<sup id="_ref-7" class="reference"><a href="#_note-7" title="">[14]</a></sup></p>
<p><a name="Possible_neuroprotection" id="Possible_neuroprotection"></a></p>
<h3><span class="editsection">[<a href="../../../a/c/a/Acamprosate.html" title="Edit section: Possible neuroprotection">edit</a>]</span> <span class="mw-headline">Possible neuroprotection</span></h3>
<p>In addition to its apparent ability to help patients refrain from drinking, some evidence suggests that acamprosate is <a href="../../../n/e/u/Neuroprotection.html" title="Neuroprotection">neuroprotective</a> (that is, it protects <a href="../../../n/e/u/Neuron.html" title="Neuron">neurons</a> from damage and death caused by effects of alcohol withdrawal and possibly other insults).<sup id="_ref-De_Witte_2005_1" class="reference"><a href="#_note-De_Witte_2005" title="">[12]</a></sup> For example, acamprosate has been found to protect <a href="../../../c/e/l/Cell_culture.html" title="Cell culture">cultured cells</a> from damage induced by <a href="../../../i/s/c/Ischemia.html" title="Ischemia">ischemia</a> (inadequate blood flow).<sup id="_ref-Engelhard2006_0" class="reference"><a href="#_note-Engelhard2006" title="">[15]</a></sup> Also, the drug protected infant hamsters from <a href="../../../b/r/a/Brain_damage.html" title="Brain damage">brain damage</a> induced by injections of the toxin <a href="../../../i/b/o/Ibotenic_acid.html" title="Ibotenic acid">ibotenic acid</a>, which exacerbates <a href="../../../e/x/c/Excitotoxicity.html" title="Excitotoxicity">excitotoxicity</a> (the harmful overactivation of <a href="../../../g/l/u/Glutamate.html" title="Glutamate">glutamate</a> <a href="../../../r/e/c/Receptor_%28biochemistry%29.html" title="Receptor (biochemistry)">receptors</a>.<sup id="_ref-Adde2005_0" class="reference"><a href="#_note-Adde2005" title="">[16]</a></sup></p>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="../../../a/c/a/Acamprosate.html" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<div class="references-small" style="-moz-column-count:2; column-count:2};">
<ol class="references">
<li id="_note-fda">^ <a href="#_ref-fda_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-fda_1" title=""><sup><i><b>b</b></i></sup></a> <a href="#_ref-fda_2" title=""><sup><i><b>c</b></i></sup></a> <a href="#_ref-fda_3" title=""><sup><i><b>d</b></i></sup></a> <a href="#_ref-fda_4" title=""><sup><i><b>e</b></i></sup></a> <a href="#_ref-fda_5" title=""><sup><i><b>f</b></i></sup></a> <a href="#_ref-fda_6" title=""><sup><i><b>g</b></i></sup></a> <a href="#_ref-fda_7" title=""><sup><i><b>h</b></i></sup></a> <a href="http://www.fda.gov/cder/foi/label/2004/21431lbl.pdf" class="external text" title="http://www.fda.gov/cder/foi/label/2004/21431lbl.pdf" rel="nofollow">Campral Description</a> (PDF). FDA. Retrieved on <a href="../../../j/a/n/January_8.html" title="January 8">January 8</a>, <a href="../../../2/0/0/2007.html" title="2007">2007</a>.</li>
<li id="_note-deluca"><b><a href="#_ref-deluca_0" title="">^</a></b> DeLuca, Alexander. <a href="http://www.doctordeluca.com/Documents/AcamprosateSummary.htm" class="external text" title="http://www.doctordeluca.com/Documents/AcamprosateSummary.htm" rel="nofollow">Acamprosate (Campral): Medication for Alcohol Abuse and Alcoholism Treatment</a>. doctordeluca.com. Retrieved on <a href="../../../j/a/n/January_8.html" title="January 8">January 8</a>, <a href="../../../2/0/0/2007.html" title="2007">2007</a>.</li>
<li id="_note-americanfamilyphysician"><b><a href="#_ref-americanfamilyphysician_0" title="">^</a></b> Williams SH. (2005). "<a href="http://www.aafp.org/afp/20051101/1775.html" class="external text" title="http://www.aafp.org/afp/20051101/1775.html" rel="nofollow">Medications for treating alcohol dependence</a>". <i>American Family Physician</i> <b>72</b> (9): 1775-1780. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16300039" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16300039">PMID 16300039</a></li>
<li id="_note-Mason2001"><b><a href="#_ref-Mason2001_0" title="">^</a></b> Mason BJ. "Treatment of alcohol-dependent outpatients with acamprosate: a clinical review". <i>J Clin Psychiatry</i> 2001;<b>62</b>(suppl 20):42-8. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11584875" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11584875">PMID 11584875</a></li>
<li id="_note-0"><b><a href="#_ref-0" title="">^</a></b> <a href="http://www.drugs.com/mtm/acamprosate.html" class="external text" title="http://www.drugs.com/mtm/acamprosate.html" rel="nofollow">Acamprosate</a>. drugs.com (<a href="../../../2/0/0/2005.html" title="2005">2005</a>-<a href="../../../m/a/r/March_25.html" title="March 25">03-25</a>). Retrieved on <a href="../../../j/a/n/January_8.html" title="January 8">January 8</a>, <a href="../../../2/0/0/2007.html" title="2007">2007</a>.</li>
<li id="_note-1"><b><a href="#_ref-1" title="">^</a></b> <a href="http://www.webmd.com/drugs/drug-91488-Acamprosate+Oral.aspx?drugid=91488&amp;drugname=Acamprosate+Oral&amp;pagenumber=5" class="external text" title="http://www.webmd.com/drugs/drug-91488-Acamprosate+Oral.aspx?drugid=91488&amp;drugname=Acamprosate+Oral&amp;pagenumber=5" rel="nofollow">Acamprosate Oral - Who should not take this medication?</a>. WebMD.com. Retrieved on <a href="../../../j/a/n/January_8.html" title="January 8">January 8</a>, <a href="../../../2/0/0/2007.html" title="2007">2007</a>.</li>
<li id="_note-2"><b><a href="#_ref-2" title="">^</a></b> <a href="http://www.fda.gov/bbs/topics/answers/2004/ANS01302.html" class="external text" title="http://www.fda.gov/bbs/topics/answers/2004/ANS01302.html" rel="nofollow">FDA Approves New Drug for Treatment of Alcoholism</a>. FDA (<a href="../../../2/0/0/2004.html" title="2004">2004</a>-<a href="../../../j/u/l/July_29.html" title="July 29">07-29</a>). Retrieved on <a href="../../../j/a/n/January_8.html" title="January 8">January 8</a>, <a href="../../../2/0/0/2007.html" title="2007">2007</a>.</li>
<li id="_note-Mason2006"><b><a href="#_ref-Mason2006_0" title="">^</a></b> <cite style="font-style:normal">Mason, BJ; Goodman AM, Chabac S, Lehert P (2006). "Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: The role of patient motivation". <i>J Psychiatr Res</i> <b>40</b> (5): 383-393. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16546214" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16546214">PMID 16546214</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Effect+of+oral+acamprosate+on+abstinence+in+patients+with+alcohol+dependence+in+a+double-blind%2C+placebo-controlled+trial%3A+The+role+of+patient+motivation&amp;rft.title=J+Psychiatr+Res&amp;rft.jtitle=J+Psychiatr+Res&amp;rft.date=2006&amp;rft.volume=40&amp;rft.issue=5&amp;rft.aulast=Mason&amp;rft.aufirst=BJ&amp;rft.pages=383-393">&#160;</span></li>
<li id="_note-3"><b><a href="#_ref-3" title="">^</a></b> <cite style="font-style:normal">Feeney, GF; Connor JP, Young RM, Tucker J, McPherson A (2006). "Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: A single centre's experience with pharmacotherapy". <i>Alcohol Alcohol</i> <b>41</b> (3): 321-327. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16467406" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16467406">PMID 16467406</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Combined+acamprosate+and+naltrexone%2C+with+cognitive+behavioural+therapy+is+superior+to+either+medication+alone+for+alcohol+abstinence%3A+A+single+centre%27s+experience+with+pharmacotherapy&amp;rft.title=Alcohol+Alcohol&amp;rft.jtitle=Alcohol+Alcohol&amp;rft.date=2006&amp;rft.volume=41&amp;rft.issue=3&amp;rft.aulast=Feeney&amp;rft.aufirst=GF&amp;rft.pages=321-327">&#160;</span></li>
<li id="_note-4"><b><a href="#_ref-4" title="">^</a></b> Tsai G, Coyle JT. 1998. The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annual Review of Medicine, <b>49</b>: 173-184. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9509257" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9509257">PMID 9509257</a>. Retrieved on <a href="../../../m/a/r/March_4.html" title="March 4">March 4</a>, <a href="../../../2/0/0/2007.html" title="2007">2007</a>.</li>
<li id="_note-5"><b><a href="#_ref-5" title="">^</a></b> Tsai GE, Ragan P, Chang R, Chen S, Linnoila VM, Coyle JT. (1998). <a href="http://ajp.psychiatryonline.org/cgi/content/full/155/6/726" class="external text" title="http://ajp.psychiatryonline.org/cgi/content/full/155/6/726" rel="nofollow">"Increased glutamatergic neurotransmission and oxidative stress after alcohol withdrawal."</a> <i>American Journal of Psychiatry</i>, <b>155</b> (6): 726-732. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9619143" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9619143">PMID 9619143</a>. Retrieved on <a href="../../../m/a/r/March_4.html" title="March 4">March 4</a>, <a href="../../../2/0/0/2007.html" title="2007">2007</a>.</li>
<li id="_note-De_Witte_2005">^ <a href="#_ref-De_Witte_2005_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-De_Witte_2005_1" title=""><sup><i><b>b</b></i></sup></a> De Witte P, Littleton J, Parot P, Koob G. (2005). "Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action." <i>CNS Drugs</i> <b>19</b> (6): 517-537. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15963001" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15963001">PMID 15963001</a>. Retrieved on <a href="../../../m/a/r/March_4.html" title="March 4">March 4</a>, <a href="../../../2/0/0/2007.html" title="2007">2007</a>.</li>
<li id="_note-6"><b><a href="#_ref-6" title="">^</a></b> Mayer S, Harris BR, Gibson DA, Blanchard JA, Prendergast MA, Holley RC, Littleton J. (2002). "Acamprosate, MK-801, and ifenprodil inhibit neurotoxicity and calcium entry induced by ethanol withdrawal in organotypic slice cultures from neonatal rat hippocampus." <i>Alcoholism, Clinical and Experimental Research</i>, <b>26</b> (10): 1468-1478. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12394279" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12394279">PMID 12394279</a>. Retrieved on <a href="../../../m/a/r/March_4.html" title="March 4">March 4</a>, <a href="../../../2/0/0/2007.html" title="2007">2007</a>.</li>
<li id="_note-7"><b><a href="#_ref-7" title="">^</a></b> al Qatari M, Khan S, Harris B, Littleton J. (2001). "Acamprosate is neuroprotective against glutamate-induced excitotoxicity when enhanced by ethanol withdrawal in neocortical cultures of fetal rat brain." <i>Alcoholism, Clinical and Experimental Research</i> <b>25</b> (9): 1276-1283. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11584146" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11584146">PMID 11584146</a>. Retrieved on <a href="../../../m/a/r/March_4.html" title="March 4">March 4</a>, <a href="../../../2/0/0/2007.html" title="2007">2007</a>.</li>
<li id="_note-Engelhard2006"><b><a href="#_ref-Engelhard2006_0" title="">^</a></b> <cite style="font-style:normal">Engelhard, K; Werner C, Lu H, Mollenberg O, Zieglgansberger W, Kochs E (2006). "The neuroprotective effect of the glutamate antagonist acamprosate following experimental cerebral ischemia. A study with the lipid peroxidase inhibitor u-101033e". <i>Anaesthesist</i> <b>49</b> (9): 816-821. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11076270" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11076270">PMID 11076270</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=The+neuroprotective+effect+of+the+glutamate+antagonist+acamprosate+following+experimental+cerebral+ischemia.+A+study+with+the+lipid+peroxidase+inhibitor+u-101033e&amp;rft.title=Anaesthesist&amp;rft.jtitle=Anaesthesist&amp;rft.date=2006&amp;rft.volume=49&amp;rft.issue=9&amp;rft.aulast=Engelhard&amp;rft.aufirst=K&amp;rft.pages=816-821">&#160;</span></li>
<li id="_note-Adde2005"><b><a href="#_ref-Adde2005_0" title="">^</a></b> <cite style="font-style:normal">Adde-Michel, C; Hennebert O, Laudenbach V, Marret S, Leroux P (2005). "Effect of acamprosate on neonatal excitotoxic cortical lesions in in utero alcohol-exposed hamsters". <i>Neuroscience Letters</i> <b>374</b> (2): 109-112. <a href="../../../d/i/g/Digital_object_identifier.html" title="Digital object identifier">DOI</a>:<a href="http://dx.doi.org/10.1016/j.neulet.2004.10.037" class="external text" title="http://dx.doi.org/10.1016/j.neulet.2004.10.037" rel="nofollow">10.1016/j.neulet.2004.10.037</a>. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15644274" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15644274">PMID 15644274</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Effect+of+acamprosate+on+neonatal+excitotoxic+cortical+lesions+in+in+utero+alcohol-exposed+hamsters&amp;rft.title=Neuroscience+Letters&amp;rft.jtitle=Neuroscience+Letters&amp;rft.date=2005&amp;rft.volume=374&amp;rft.issue=2&amp;rft.aulast=Adde-Michel&amp;rft.aufirst=C&amp;rft.pages=109-112&amp;rft_id=info:doi/10.1016%2Fj.neulet.2004.10.037">&#160;</span></li>
</ol>
</div>

<!-- 
Pre-expand include size: 61669 bytes
Post-expand include size: 19745 bytes
Template argument size: 12530 bytes
Maximum: 2048000 bytes
-->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org../../../a/c/a/Acamprosate.html">http://en.wikipedia.org../../../a/c/a/Acamprosate.html</a>"</div>
	    <div id="catlinks"><p class='catlinks'><a href="../../../c/a/t/Special%7ECategories_101d.html" title="Special:Categories">Categories</a>: <span dir='ltr'><a href="../../../d/r/u/Category%7EDrug_pages_needing_formula_fontification_abd9.html" title="Category:Drug pages needing formula fontification">Drug pages needing formula fontification</a></span> | <span dir='ltr'><a href="../../../a/l/c/Category%7EAlcohol_abuse_da8e.html" title="Category:Alcohol abuse">Alcohol abuse</a></span> | <span dir='ltr'><a href="../../../d/r/u/Category%7EDrugs_b475.html" title="Category:Drugs">Drugs</a></span></p></div>	    <!-- end content -->
	    <div class="visualClear"></div>
	  </div>
	</div>
      </div>
      <div id="column-one">
	<div id="p-cactions" class="portlet">
	  <h5>Views</h5>
	  <ul>
	    <li id="ca-nstab-main"
	       class="selected"	       ><a href="../../../a/c/a/Acamprosate.html">Article</a></li><li id="ca-talk"
	       	       ><a href="../../../a/c/a/Talk%7EAcamprosate_8f41.html">Discussion</a></li><li id="ca-current"
	       	       ><a href="http://en.wikipedia.org/wiki/Acamprosate">Current revision</a></li>	  </ul>
	</div>
	<div class="portlet" id="p-logo">
	  <a style="background-image: url(../../../images/wiki-en.png);"
	    href="../../../index.html"
	    title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
	  <h5>Navigation</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-Main-page"><a href="../../../index.html">Main page</a></li>
	     	      <li id="n-Contents"><a href="../../../c/o/n/Wikipedia%7EContents_3181.html">Contents</a></li>
	     	      <li id="n-Featured-content"><a href="../../../f/e/a/Wikipedia%7EFeatured_content_24ba.html">Featured content</a></li>
	     	      <li id="n-currentevents"><a href="../../../c/u/r/Portal%7ECurrent_events_bb60.html">Current events</a></li>
	     	    </ul>
	  </div>
	</div>
		<div class='portlet' id='p-interaction'>
	  <h5>interaction</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-About-Wikipedia"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html">About Wikipedia</a></li>
	     	      <li id="n-portal"><a href="../../../c/o/m/Wikipedia%7ECommunity_Portal_6a3c.html">Community portal</a></li>
	     	      <li id="n-contact"><a href="../../../c/o/n/Wikipedia%7EContact_us_afd6.html">Contact us</a></li>
	     	      <li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Fundraising">Make a donation</a></li>
	     	      <li id="n-help"><a href="../../../c/o/n/Help%7EContents_22de.html">Help</a></li>
	     	    </ul>
	  </div>
	</div>
		<div id="p-search" class="portlet">
	  <h5><label for="searchInput">Search</label></h5>
	  <div id="searchBody" class="pBody">
	    <form action="javascript:goToStatic(3)" id="searchform"><div>
	      <input id="searchInput" name="search" type="text"
	        accesskey="f" value="" />
	      <input type='submit' name="go" class="searchButton" id="searchGoButton"
	        value="Go" />
	    </div></form>
	  </div>
	</div>
	<div id="p-lang" class="portlet">
	  <h5>In other languages</h5>
	  <div class="pBody">
	    <ul>
	      	      <li>
	      <a href="../../../../de/a/c/a/Acamprosat.html">Deutsch</a>
	      </li>
	      	      <li>
	      <a href="../../../../sv/c/a/m/Campral.html">Svenska</a>
	      </li>
	      	    </ul>
	  </div>
	</div>
	      </div><!-- end of the left (by default at least) column -->
      <div class="visualClear"></div>
      <div id="footer">
    <div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="../../../skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>	<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="../../../images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>	<ul id="f-list">
	  	  	  <li id="f-credits">This page was last modified 18:19, 4 March 2007 by Wikipedia user <a href="../../../d/e/l/User%7EDelldot_cc92.html" title="User:Delldot">Delldot</a>. Based on work by Wikipedia user(s) <a href="../../../s/a/n/User%7ESandyGeorgia_1007.html" title="User:SandyGeorgia">SandyGeorgia</a>, <a href="../../../m/e/s/User%7EMessedrocker_53b5.html" title="User:Messedrocker">Messedrocker</a>, <a href="../../../a/g/e/User%7EAgentPeppermint_eeef.html" title="User:AgentPeppermint">AgentPeppermint</a>, <a href="../../../s/t/e/User%7EStevenfruitsmaak_e31a.html" title="User:Stevenfruitsmaak">Stevenfruitsmaak</a>, <a href="../../../f/v/a/User%7EFvasconcellos_4804.html" title="User:Fvasconcellos">Fvasconcellos</a>, <a href="../../../a/n/t/User%7EAntiVandalBot_aa84.html" title="User:AntiVandalBot">AntiVandalBot</a>, <a href="../../../s/a/g/User%7ESagabot_42ff.html" title="User:Sagabot">Sagabot</a>, <a href="../../../d/a/r/User%7EDarklilac_3c11.html" title="User:Darklilac">Darklilac</a>, <a href="../../../u/r/o/User%7EUrod_afcd.html" title="User:Urod">Urod</a>, <a href="../../../j/l/i/User%7EJlittlet_048e.html" title="User:Jlittlet">Jlittlet</a>, <a href="../../../h/y/d/User%7EHydro2_0b31.html" title="User:Hydro2">Hydro2</a>, <a href="../../../e/p/o/User%7EEpolk_d8a6.html" title="User:Epolk">Epolk</a>, <a href="../../../d/a/v/User%7EDavid_Andel_02c9.html" title="User:David Andel">David Andel</a>, <a href="../../../a/r/c/User%7EArcadian_5c4b.html" title="User:Arcadian">Arcadian</a>, <a href="../../../k/e/r/User%7EKershner_cf22.html" title="User:Kershner">Kershner</a>, <a href="../../../g/j/e/User%7EGJeffery_6806.html" title="User:GJeffery">GJeffery</a>, <a href="../../../b/o/b/User%7EBobblewik_fbc0.html" title="User:Bobblewik">Bobblewik</a>, <a href="../../../d/r/a/User%7EDragonflySixtyseven_c6ee.html" title="User:DragonflySixtyseven">DragonflySixtyseven</a>, <a href="../../../f/r/e/User%7EFreplySpang_52d7.html" title="User:FreplySpang">FreplySpang</a> and Matteo2000 and Anonymous user(s) of Wikipedia.</li>	  <li id="f-copyright">All text is available under the terms of the <a class='internal' href="../../../t/e/x/Wikipedia%7EText_of_the_GNU_Free_Documentation_License_702a.html" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="../../../c/o/p/Wikipedia%7ECopyrights_92c4.html" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc</a>., a US-registered <a class='internal' href="../../../5/0/1/501%28c%29.html#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="../../../n/o/n/Non-profit_organization.html" title="Non-profit organization">nonprofit</a> <a href="../../../c/h/a/Charitable_organization.html" title="Charitable organization">charity</a>.<br /></li>	  <li id="f-about"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html" title="Wikipedia:About">About Wikipedia</a></li>	  <li id="f-disclaimer"><a href="../../../g/e/n/Wikipedia%7EGeneral_disclaimer_3e44.html" title="Wikipedia:General disclaimer">Disclaimers</a></li>	  	</ul>
      </div>
    </div>
  </body>
</html>
